Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.00 0.00 (-0.50%)
As of: Oct 2, 2026 · 1:50 PM EDT

Phio Pharmaceuticals (PHIO) Cash & Equivalents (2011 - 2026)

Updated

Phio Pharmaceuticals (PHIO) posted Cash & Equivalents of $13 million for Q2 2026, up 20.6% from $10.78 million a year earlier but down 23.7% from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Cash & Equivalents (2011 - 2026) Analysis & Trends

At the end of FY2025, Phio Pharmaceuticals' Cash & Equivalents came in at $21.03 million, up 290.8% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
  • In prior years, Phio Pharmaceuticals' Cash & Equivalents was $5.38 million in FY2024 (-36.6%), $8.49 million in FY2023 (-27.9%), $11.78 million in FY2022 (-51.0%) and $24.06 million in FY2021 (+68.9%).
  • Quarterly Cash & Equivalents has run from a low of $4.7 million in Q2 2024 to a high of $26.53 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Equivalents has increased in each of the last six quarters, with growth averaging 75.0% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2025, with growth of 290.8%; the weakest was Q2 2024, with a decline of 58.5%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $17.03 million (Q1 2026), $21.03 million (Q4 2025) and $10.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Phio Pharmaceuticals 11.97 Mn 11.97 Mn - 13.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.00 Mn
Mar 31, 2026 17.03 Mn
Dec 31, 2025 21.03 Mn
Sep 30, 2025 10.71 Mn
Jun 30, 2025 10.78 Mn
Mar 31, 2025 13.28 Mn
Dec 31, 2024 5.38 Mn
Sep 30, 2024 5.39 Mn
Jun 30, 2024 4.70 Mn
Mar 31, 2024 6.48 Mn
Dec 31, 2023 8.49 Mn
Sep 30, 2023 8.41 Mn
Jun 30, 2023 11.31 Mn
Mar 31, 2023 9.04 Mn
Dec 31, 2022 11.78 Mn
Sep 30, 2022 14.48 Mn
Jun 30, 2022 18.02 Mn
Mar 31, 2022 20.46 Mn
Dec 31, 2021 24.06 Mn
Sep 30, 2021 26.53 Mn
API Access

Phio Pharmaceuticals Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHIO&period=max&api_key=YOUR_API_KEY